| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Dec 17, 2025 | Royalty Pharma plc | CFO | Sell | 20.0 | -69,582 | -10.08% | ✓ | $2.7M |
| Dec 1, 2025 | Dec 3, 2025 | Royalty Pharma plc | CFO | Sell | 23.8 | -69,582 | -9.16% | ✓ | $2.8M |
| Nov 24, 2025 | Nov 26, 2025 | Royalty Pharma plc | CFO | Sell | 23.8 | -69,582 | -8.39% | ✓ | $2.7M |
| Nov 17, 2025 | Nov 19, 2025 | Royalty Pharma plc | CFO | Sell | 23.8 | -69,594 | -7.74% | ✓ | $2.7M |
| Aug 9, 2023 | Aug 11, 2023 | Royalty Pharma plc | CFO | Sell | 17.5 | -75,000 | -8.19% | ✗ | $2.3M |
| Jul 12, 2023 | Jul 14, 2023 | Royalty Pharma plc | CFO | Sell | 17.5 | -75,000 | -7.57% | ✗ | $2.3M |
| Nov 8, 2022 | Nov 10, 2022 | Royalty Pharma plc | CFO | Sell | 36.3 | -24,500 | -2.41% | ✓ | $1.1M |
| Nov 2, 2022 | Nov 4, 2022 | Royalty Pharma plc | CFO | Sell | 47.5 | -5,500 | -0.54% | ✓ | $236.8K |
| Aug 1, 2022 | Aug 3, 2022 | Royalty Pharma plc | CFO | Sell | 36.3 | -30,000 | -2.86% | ✓ | $1.3M |
| Mar 3, 2021 | Mar 5, 2021 | Royalty Pharma plc | CFO | Sell | 5.0 | -100,000 | -28.54% | ✓ | $4.5M |
| Mar 2, 2021 | Mar 4, 2021 | Royalty Pharma plc | CFO | Sell | 10.0 | -100,000 | -22.20% | ✓ | $4.7M |
| Jun 18, 2020 | Jun 23, 2020 | Royalty Pharma plc | CFO | Buy | 95.0 | +2,950 | 100.00% | ✗ | $82.6K |